Italian Home/Self Testing Coagulation Market Research 2024: Diabetes, Pregnancy, Ovulation, Occult Blood Sales Forecasts, Technology Trends, and Competitive Strategies
22 juil. 2024 05h47 HE
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Home/Self-Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood-- Sales Forecasts, Technology Trends, Competitive Strategies" report has...
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
16 juil. 2024 08h30 HE
|
Biodexa Pharmaceuticals PLC
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage...
Aeroflow Health Launches Personalized Nutrition Services, Harnessing the Power of Food to Improve Health & Wellness Outcomes
27 juin 2024 08h27 HE
|
Aeroflow Health
With Aeroflow Nutrition Services, patients receive a transparent, compassionate customer experience from a Registered Dietitian.
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
25 juin 2024 07h00 HE
|
Fractyl Health, Inc.
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care
24 juin 2024 10h48 HE
|
Cardiometabolic Health Congress
Boca Raton, FL, June 24, 2024 (GLOBE NEWSWIRE) -- The ADA 2024 Scientific Sessions center on the latest cutting-edge advances in diabetes research, prevention, and care. The event will be held June...
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
24 juin 2024 06h30 HE
|
Embecta Corp.
embecta-sponsored abstracts presented at ADA's 84th Scientific Sessions highlight unmet need for patch pumps with 300u insulin reservoir
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
24 juin 2024 06h00 HE
|
Fractyl Health, Inc.
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
23 juin 2024 13h30 HE
|
Fractyl Health, Inc.
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Platform at ADA 2024.
INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
22 juin 2024 08h00 HE
|
MannKind
INHALE-3 STUDY REVEALS POSITIVE READOUT IN HEAD-TO-HEAD COMPARISON OF INHALED INSULIN VS. USUAL CARE IN T1D; NEW DATA PRESENTED
SAb Biotherapeutics Rebrands as SAB BIO
20 juin 2024 07h20 HE
|
SAB Biotherapeutics, Inc.
New name, logo and website updates, stock symbol will remain SABS With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE...